Quick Answer
TENAX THERAPEUTICS, INC. reported Cash and Equivalents of $2.12 million for fiscal year 2022.
TENAX THERAPEUTICS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2022 | $2.12M | -62.0% |
| 2021 | $5.58M | -10.7% |
| 2020 | $6.25M | +27.4% |
| 2019 | $4.91M | -60.3% |
| 2018 | $12.37M | +670.6% |
| 2017 | $1.60M | -83.9% |
| 2016 | $10.00M | +173.1% |
| 2015 | $3.66M | -53.8% |
| 2015 | $7.93M | -86.4% |
| 2014 | $58.32M | +7343.3% |
| 2013 | $783.5K | -58.3% |
| 2012 | $1.88M | +97.5% |
| 2011 | $951.9K | +50.5% |
| 2010 | $632.7K | — |
| 1967 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| June 30, 2023 | $13.39M | +85.3% | -7.1% |
| March 31, 2023 | $14.41M | +402.5% | +578.8% |
| December 31, 2022 | $2.12M | -62.0% | -44.2% |
| September 30, 2022 | $3.81M | -54.4% | -47.3% |
| June 30, 2022 | $7.23M | +332.5% | +152.0% |
| March 31, 2022 | $2.87M | -18.9% | -48.6% |
| December 31, 2021 | $5.58M | -10.7% | -33.2% |
| September 30, 2021 | $8.35M | +1.4% | +399.8% |
- TENAX THERAPEUTICS, INC. showed a decrease of -62.0% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from TENAX THERAPEUTICS, INC.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 31, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: